Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of July 2026, specifically reporting on an Extraordinary General Meeting (EGM) held on July 6, 2026, in Beijing, China. The meeting addressed significant corporate governance matters regarding the company's capital structure and governing documents.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the results of shareholder votes regarding capital restructuring.
Material Changes
Shareholders approved a major restructuring of the company's authorized share capital:
- Capital Reduction: The par value of Class A and Class B Ordinary Shares was reduced from US$0.32 to US$0.0000001 per share.
- Authorized Capital Adjustment: The total authorized share capital was reduced from US$35,200,000,000,000 to US$11,000,000.
- Share Subdivision: Authorized but unissued shares were subdivided to align with the new par value.
- Loss Elimination: The credit arising from the capital reduction is to be transferred to a distributable reserve account, which may be used to eliminate accumulated losses.
- Governing Documents: The Ninth Amended and Restated Memorandum and Articles of Association were adopted to reflect these changes.
Voting Results and Quorum
A quorum was present, with more than one-third of the voting shares represented. The voting power is weighted, with Class B shares carrying 30 votes each compared to 1 vote for Class A shares.
| Resolution | For | Against | Abstain |
|---|---|---|---|
| Share Capital Reduction | 10,000,995 | 7,952 | 12 |
| Adoption of Ninth Amended M&AA | 10,001,225 | 7,690 | 44 |
| Adjournment Proposal | 10,001,059 | 7,888 | 12 |
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies were disclosed in this document, other than the standard procedural requirement to comply with the Companies Act (Revised) for the share capital reduction.
Investor Verification Checklist
- Verify the effective date of the share capital reduction and the issuance of new share certificates reflecting the US$0.0000001 par value.
- Confirm the impact of the capital reduction on the company's accumulated losses and retained earnings in the next financial report.
- Review the Ninth Amended and Restated Memorandum and Articles of Association for any other governance changes beyond the capital structure.
- Check for subsequent filings regarding the actual implementation of the share subdivision for unissued shares.